Olivia Pagani
Olivia Pagani
IOSI, University of Geneva
Verified email at eoc.ch
Title
Cited by
Cited by
Year
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
F Cardoso, A Costa, L Norton, E Senkus, M Aapro, F Andre, CH Barrios, ...
Annals of oncology 25 (10), 1871-1888, 2014
6602014
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer
O Pagani, MM Regan, BA Walley, GF Fleming, M Colleoni, I Láng, ...
New England Journal of Medicine 371 (2), 107-118, 2014
6422014
3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3)
F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ...
Annals of Oncology 28 (1), 16-33, 2017
5672017
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G Curigliano, HJ Burstein, E P Winer, M Gnant, P Dubsky, S Loibl, ...
Annals of Oncology 28 (8), 1700-1712, 2017
5592017
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
F Cardoso, E Senkus, A Costa, E Papadopoulos, M Aapro, F André, ...
Annals of Oncology 29 (8), 1634-1657, 2018
4332018
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
BC Pestalozzi, D Zahrieh, KN Price, SB Holmberg, J Lindtner, J Collins, ...
Annals of Oncology 17 (6), 935-944, 2006
3512006
1st International consensus guidelines for advanced breast cancer (ABC 1)
F Cardoso, A Costa, L Norton, D Cameron, T Cufer, L Fallowfield, ...
The Breast 21 (3), 242-252, 2012
3412012
International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?
O Pagani, E Senkus, W Wood, M Colleoni, T Cufer, S Kyriakides, A Costa, ...
Journal of the National Cancer Institute 102 (7), 456-463, 2010
3352010
CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial
MM Regan, B Leyland-Jones, M Bouzyk, O Pagani, W Tang, R Kammler, ...
Journal of the National Cancer Institute 104 (6), 441-451, 2012
3212012
Docetaxel (Taxotere®)-cisplatin (TC): An effective drug combination in gastric carcinoma
AD Roth, R Maibach, G Martinelli, N Fazio, MS Aapro, O Pagani, R Morant, ...
Annals of oncology 11 (3), 301-306, 2000
3102000
Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial
M Procter, TM Suter, E de Azambuja, U Dafni, V van Dooren, ...
Journal of clinical oncology 28 (21), 3422-3428, 2010
2782010
The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer
F Cardoso, S Loibl, O Pagani, A Graziottin, P Panizza, L Martincich, ...
European journal of cancer 48 (18), 3355-3377, 2012
2492012
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy
F Cardoso, PL Bedard, EP Winer, O Pagani, E Senkus-Konefka, ...
Journal of the National Cancer Institute 101 (17), 1174-1181, 2009
2492009
Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
P Francis, O Pagani, M Regan
The New England Journal of Medicine 379 (17), 1684-1685, 2018
177*2018
Tailoring adjuvant endocrine therapy for premenopausal breast cancer
PA Francis, O Pagani, GF Fleming, BA Walley, M Colleoni, I Láng, ...
New England Journal of Medicine 379 (2), 122-137, 2018
1752018
High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel
D Crivellari, O Pagani, A Veronesi, D Lombardi, F Nole, B Th¨ rlimann, ...
Annals of oncology 12 (3), 353-356, 2001
1572001
ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3)
S Paluch-Shimon, O Pagani, AH Partridge, O Abulkhair, MJ Cardoso, ...
The Breast 35, 203-217, 2017
1462017
First international consensus guidelines for breast cancer in young women (BCY1)
AH Partridge, O Pagani, O Abulkhair, S Aebi, F Amant, HA Azim Jr, ...
The breast 23 (3), 209-220, 2014
1372014
Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor–positive, human epidermal growth factor receptor 2–negative early breast cancer …
MM Regan, PA Francis, O Pagani, GF Fleming, BA Walley, G Viale, ...
Journal of Clinical Oncology 34 (19), 2221, 2016
1162016
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined …
J Bernhard, W Luo, K Ribi, M Colleoni, HJ Burstein, C Tondini, G Pinotti, ...
The Lancet Oncology 16 (7), 848-858, 2015
1122015
The system can't perform the operation now. Try again later.
Articles 1–20